Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

413 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Sequential Treatment with Pazopanib and Everolimus in Metastatic Renal Cell Carcinoma.
Rossetti S, D'Aniello C, Iovane G, Scagliarini S, Laterza MM, De Vita F, Savastano C, Cartenì G, Porricelli MA, Berretta M, Pisconti S, Facchini G, Cavaliere C. Rossetti S, et al. Among authors: berretta m. Front Pharmacol. 2017 Jul 20;8:484. doi: 10.3389/fphar.2017.00484. eCollection 2017. Front Pharmacol. 2017. PMID: 28775690 Free PMC article.
From Clinical Trials to the Front Line: Vinflunine for Treatment of Urothelial Cell Carcinoma at the National Cancer Institute of Naples.
Facchini G, Della Pepa C, Cavaliere C, Cecere SC, Di Napoli M, D'Aniello C, Crispo A, Iovane G, Maiolino P, Tramontano T, Piscitelli R, Pisconti S, Montella M, Berretta M, Sorrentino D, Perdonà S, Pignata S. Facchini G, et al. Among authors: berretta m. Front Pharmacol. 2016 May 3;7:110. doi: 10.3389/fphar.2016.00110. eCollection 2016. Front Pharmacol. 2016. PMID: 27199753 Free PMC article.
Very Early PSA Response to Abiraterone in mCRPC Patients: A Novel Prognostic Factor Predicting Overall Survival.
Facchini G, Caffo O, Ortega C, D'Aniello C, Di Napoli M, Cecere SC, Della Pepa C, Crispo A, Maines F, Ruatta F, Iovane G, Pisconti S, Montella M, Berretta M, Pignata S, Cavaliere C. Facchini G, et al. Among authors: berretta m. Front Pharmacol. 2016 May 18;7:123. doi: 10.3389/fphar.2016.00123. eCollection 2016. Front Pharmacol. 2016. PMID: 27242530 Free PMC article.
Pazopanib in Metastatic Renal Cancer: A "Real-World" Experience at National Cancer Institute "Fondazione G. Pascale".
Cecere SC, Rossetti S, Cavaliere C, Della Pepa C, Di Napoli M, Crispo A, Iovane G, Piscitelli R, Sorrentino D, Ciliberto G, Maiolino P, Muto P, Perdonà S, Berretta M, Pignata S, Facchini G, D'Aniello C. Cecere SC, et al. Among authors: berretta m. Front Pharmacol. 2016 Aug 31;7:287. doi: 10.3389/fphar.2016.00287. eCollection 2016. Front Pharmacol. 2016. PMID: 27630568 Free PMC article.
Axitinib after Sunitinib in Metastatic Renal Cancer: Preliminary Results from Italian "Real-World" SAX Study.
D'Aniello C, Vitale MG, Farnesi A, Calvetti L, Laterza MM, Cavaliere C, Della Pepa C, Conteduca V, Crispo A, De Vita F, Grillone F, Ricevuto E, De Tursi M, De Vivo R, Di Napoli M, Cecere SC, Iovane G, Amore A, Piscitelli R, Quarto G, Pisconti S, Ciliberto G, Maiolino P, Muto P, Perdonà S, Berretta M, Naglieri E, Galli L, Cartenì G, De Giorgi U, Pignata S, Facchini G, Rossetti S. D'Aniello C, et al. Among authors: berretta m. Front Pharmacol. 2016 Sep 28;7:331. doi: 10.3389/fphar.2016.00331. eCollection 2016. Front Pharmacol. 2016. PMID: 27733829 Free PMC article.
Corrigendum: Pazopanib in Metastatic Renal Cancer: A "Real-World" Experience at National Cancer Institute "Fondazione G. Pascale".
Cecere SC, Rossetti S, Cavaliere C, Della Pepa C, Di Napoli M, Crispo A, Iovane G, Piscitelli R, Sorrentino D, Ciliberto G, Maiolino P, Muto P, Perdonà S, Berretta M, Pignata S, Facchini G, D'Aniello C. Cecere SC, et al. Among authors: berretta m. Front Pharmacol. 2016 Dec 5;7:468. doi: 10.3389/fphar.2016.00468. eCollection 2016. Front Pharmacol. 2016. PMID: 27924140 Free PMC article.
Current and Emerging Treatments for Metastatic Renal Cell Carcinoma.
Cavaliere C, D'Aniello C, Pepa CD, Pisconti S, Berretta M, Facchini G. Cavaliere C, et al. Among authors: berretta m. Curr Cancer Drug Targets. 2018;18(5):468-479. doi: 10.2174/1568009617666170209094030. Curr Cancer Drug Targets. 2018. PMID: 28183256 Review.
Biomarkers of Prognosis and Efficacy of Anti-angiogenic Therapy in Metastatic Clear Cell Renal Cancer.
D'Aniello C, Berretta M, Cavaliere C, Rossetti S, Facchini BA, Iovane G, Mollo G, Capasso M, Pepa CD, Pesce L, D'Errico D, Buonerba C, Di Lorenzo G, Pisconti S, De Vita F, Facchini G. D'Aniello C, et al. Among authors: berretta m. Front Oncol. 2019 Dec 11;9:1400. doi: 10.3389/fonc.2019.01400. eCollection 2019. Front Oncol. 2019. PMID: 31921657 Free PMC article. Review.
Angiogenesis Inhibitors for the Treatment of Hepatocellular Carcinoma.
Berretta M, Rinaldi L, Di Benedetto F, Lleshi A, De Re V, Facchini G, De Paoli P, Di Francia R. Berretta M, et al. Front Pharmacol. 2016 Nov 9;7:428. doi: 10.3389/fphar.2016.00428. eCollection 2016. Front Pharmacol. 2016. PMID: 27881963 Free PMC article. Review.
413 results